Aktiesnakken — November 2010
-
De har ikke nogen præcis dato for møde i Q1
-
Spørgsmål om virkning af Huntexil set over den behandlede periode. Fik ikke helt fat i det
-
Eddison research
-
Hvilken strategi er der for evt at indlincere nye stoffer
-
De vil først se endnu mere på deres interne stoffer for at se på muligheden for at tage flere at disse
-
offer hele vej frem til marekdet
-
Der er ikke nogen konkrete planer om at indlicensiere nye stoffer
-
CC slut
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind